From the comparative proteomics analysis of the doxorubicin-resistant myelogenous leukemia cells and their parental cells, protein 14 on Figure 1 was observed to be highly differentially expressed, which was identified as sorcin, a soluble resistance-related calcium-binding protein. Here, SRI is linked to myeloid leukemia.